tradingkey.logo

Eton Pharmaceuticals Inc <ETON.OQ> expected to post earnings of 5 cents a share - Earnings Preview

ReutersMay 10, 2025 12:24 AM
  • Eton Pharmaceuticals Inc ETON.OQ ETON.O is expected to show a rise in quarterly revenue when it reports results on May 13 for the period ending March 31 2025

  • The Deer Park Illinois-based company is expected to report a 89.9% increase in revenue to $15.131 million from $7.97 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Eton Pharmaceuticals Inc is for earnings of 5 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Eton Pharmaceuticals Inc is $26.00​, above​ its last closing price of $16.79. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.01

0.00

-0.02

Missed

-500.6

Sep. 30 2024

-0.01

-0.01

0.03

Beat

400

Jun. 30 2024

-0.07

-0.07

-0.12

Missed

-71.4​

Mar. 31 2024

-0.07

-0.04

-0.03

Beat

33.3

​​Dec. 31 2023

-0.04

-0.04

-0.09

Missed

-125

Sep. 30 2023

-0.10

-0.10

-0.02

Beat

80​

Jun. 30 2023

-0.09

-0.09

0.15

Beat

266.7

Mar. 31 2023

-0.14

-0.14

-0.10

Beat

28.6

This summary was machine generated May 10 at 00:24 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles